This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Biomedical Analysis Center, Academy of Military Medical Sciences, Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences. Active years: 2012-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 43 
2 out of 2 Years Active: 2012-2023
Title: Xinhua He: Innovator in Anti-Tumor Therapeutics
Introduction: Xinhua He, based in Beijing, China, is an accomplished inventor with a remarkable portfolio of five patents. His contributions primarily focus on hydroquinone compounds and their application in anti-tumor and immunomodulation therapies, marking significant advancements in the pharmaceutical field.
Latest Patents: Among Xinhua He's notable patents is the one concerning hydroquinone compounds, along with their preparation methods and uses in anti-tumor or immunomodulation therapy. This invention discloses structural formulas for hydroquinone compounds, where key variables include carbon-based alkyl, cycloalkyl, alkenyl, and aryl groups. These compounds exhibit a slow release of 2-tert-butyl-4-methoxyphenol in vivo, maintaining stable plasma concentrations over extended periods. Additionally, he developed a method for preparing a stable crystal form of 2-tert-butyl-4-methoxyphenol, crucial for enhancing the stability and environmental resistance of drugs derived from these compounds.
Career Highlights: Xinhua He has made significant contributions during his tenure at the Institute of Pharmacology and Toxicology and the Academy of Military Medical Sciences in China. His expertise in pharmacology has propelled his innovative research forward, resulting in breakthroughs in drug preparation and stability.
Collaborations: Throughout his career, Xinhua He has worked alongside notable colleagues, including Xuemin Zhang and Tao Zhou. These collaborations have fostered an environment of innovation and mutual growth, enhancing the quality of research and development in therapeutic solutions.
Conclusion: Xinhua He's innovations in the field of pharmacology, particularly in anti-tumor therapies, underscore his role as a leading inventor. His patents not only contribute to scientific knowledge but also pave the way for the development of effective treatments that hold promise for improving patient outcomes in cancer therapy. His ongoing contributions continue to inspire future research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile